Nina Bayerl's area of expertise includes IP law and competition law with a focus on patent disputes in the life sciences and tech sectors.
She advises at various legal interfaces, for example at the interface of patent law, pharmaceutical law and social law in connection with disputes in the pharma sector, or at the interface of IP law and competition law, covering the assertation of standard-essential patents. She also advises on all forms of contracts dealing with IP rights as well as on IP law issues in the context of international transactions.
Before joining Freshfields, Nina wrote a doctoral thesis on patent strategies within the pharmaceutical sector at the Max Planck Institute for Innovation and Competition as a scholarship holder.
Acting for the Novartis group in several patent infringement matters, including enforcing second medical use patents for the blockbuster drugs Glivec and Afinitor and enforcing a composition patent for Ritalin against several competitors.
Representing several pharmaceutical companies in complex biotech entitlement proceedings.
Advising major manufacturers in the telecoms industry with regard to enforcing of standard esential patents on a worldwide basis, including negotiation of respecive license agreements.
Representing Lenovo in patent litigation relating to H.264 video decoding patents.
Representing Facebook in proceedings concerning several functionalities in apps.
Advising several clients of the pharmaceutical and biotech industries on R&D cooperation agreements.